Rohin Iyer, Ph.D.

Senior Director Cell and Gene Operations, Marken

As Senior Director of Cell and Gene Operations, Dr. Rohin Iyer leads Marken’s Advanced Therapies Division, managing the critical distribution of both clinical and commercial personalized medicines. Leveraging Marken’s unique cell and gene therapy (CGT) portfolio, he oversees complex logistics across a diverse array of advanced therapeutic modalities ranging from nucleic acid therapies to CAR-T therapy, as well as the raw materials used to manufacture them. With extensive experience in portfolio management, process development and bioprocess optimization in CGT and immunotherapy, he has played an instrumental role in supporting the clinical research and development of regenerative medicines. Rohin obtained his Bachelor of Applied Science and his Doctor of Philosophy (Ph.D.) in Biomedical Engineering at the University of Toronto.

Talk to Rohin about these topics and more: 

• Biomanufacturing & process development for cell & gene therapies 
• Culture expansion of CAR-T cells, NK cells and mesenchymal stem cells 
• Cold chain logistics and supply chain considerations for ATMPs 
• Tissue engineering and regenerative medicine best practices 
• Bioreactor development and scale-up/out